代码,简称,公告标题,公告时间,公告链接
600276,恒瑞医药,恒瑞医药2025年第二次临时股东会会议资料,2025-12-25 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224896630&orgId=gssh0600276&announcementTime=2025-12-25 00:00:00
600276,恒瑞医药,恒瑞医药关于药物纳入突破性治疗品种名单的公告,2025-12-25 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224895810&orgId=gssh0600276&announcementTime=2025-12-25 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-12-25 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224895813&orgId=gssh0600276&announcementTime=2025-12-25 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-12-20 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224887407&orgId=gssh0600276&announcementTime=2025-12-20 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-12-20 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224887396&orgId=gssh0600276&announcementTime=2025-12-20 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-12-20 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224887401&orgId=gssh0600276&announcementTime=2025-12-20 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-12-20 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224887398&orgId=gssh0600276&announcementTime=2025-12-20 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-12-13 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224871980&orgId=gssh0600276&announcementTime=2025-12-13 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-12-13 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224871979&orgId=gssh0600276&announcementTime=2025-12-13 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-12-13 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224871991&orgId=gssh0600276&announcementTime=2025-12-13 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-12-13 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224871986&orgId=gssh0600276&announcementTime=2025-12-13 00:00:00
600276,恒瑞医药,恒瑞医药关于召开2025年第二次临时股东会的通知,2025-12-11 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224866509&orgId=gssh0600276&announcementTime=2025-12-11 00:00:00
600276,恒瑞医药,恒瑞医药公司章程修正案,2025-12-11 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224866504&orgId=gssh0600276&announcementTime=2025-12-11 00:00:00
600276,恒瑞医药,恒瑞医药第九届董事会第二十一次会议决议公告,2025-12-11 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224866523&orgId=gssh0600276&announcementTime=2025-12-11 00:00:00
600276,恒瑞医药,恒瑞医药关于公司药品纳入国家医保目录的公告,2025-12-08 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224856686&orgId=gssh0600276&announcementTime=2025-12-08 00:00:00
600276,恒瑞医药,恒瑞医药第九届董事会第二十次会议决议公告,2025-12-04 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224847343&orgId=gssh0600276&announcementTime=2025-12-04 00:00:00
600276,恒瑞医药,恒瑞医药关于回购公司A股股份的进展公告,2025-12-03 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224843485&orgId=gssh0600276&announcementTime=2025-12-03 00:00:00
600276,恒瑞医药,恒瑞医药关于药品上市许可申请获受理的提示性公告,2025-12-03 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224843478&orgId=gssh0600276&announcementTime=2025-12-03 00:00:00
600276,恒瑞医药,H股公告-证券变动月报表,2025-12-03 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224843476&orgId=gssh0600276&announcementTime=2025-12-03 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-11-28 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224830652&orgId=gssh0600276&announcementTime=2025-11-28 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-11-28 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224830619&orgId=gssh0600276&announcementTime=2025-11-28 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-11-26 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224824873&orgId=gssh0600276&announcementTime=2025-11-26 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-11-26 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224824861&orgId=gssh0600276&announcementTime=2025-11-26 00:00:00
600276,恒瑞医药,恒瑞医药关于药品上市许可申请获受理的提示性公告,2025-11-25 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224822551&orgId=gssh0600276&announcementTime=2025-11-25 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册批准的公告,2025-11-25 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224822561&orgId=gssh0600276&announcementTime=2025-11-25 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-11-22 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224820277&orgId=gssh0600276&announcementTime=2025-11-22 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-11-22 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224820276&orgId=gssh0600276&announcementTime=2025-11-22 00:00:00
600276,恒瑞医药,恒瑞医药关于回购公司A股股份的进展公告,2025-11-22 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224820273&orgId=gssh0600276&announcementTime=2025-11-22 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-11-22 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224820407&orgId=gssh0600276&announcementTime=2025-11-22 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-11-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224817062&orgId=gssh0600276&announcementTime=2025-11-21 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-11-18 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224808833&orgId=gssh0600276&announcementTime=2025-11-18 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-11-18 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224808831&orgId=gssh0600276&announcementTime=2025-11-18 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-11-18 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224808829&orgId=gssh0600276&announcementTime=2025-11-18 00:00:00
600276,恒瑞医药,恒瑞医药关于2022年员工持股计划第三个锁定期解锁执行完毕的公告,2025-11-15 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224805477&orgId=gssh0600276&announcementTime=2025-11-15 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-11-14 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224803359&orgId=gssh0600276&announcementTime=2025-11-14 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-11-12 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224798673&orgId=gssh0600276&announcementTime=2025-11-12 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-11-11 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224795480&orgId=gssh0600276&announcementTime=2025-11-11 00:00:00
600276,恒瑞医药,恒瑞医药2025年A股员工持股计划第一次持有人会议决议公告,2025-11-08 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224793062&orgId=gssh0600276&announcementTime=2025-11-08 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-11-08 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224793060&orgId=gssh0600276&announcementTime=2025-11-08 00:00:00
600276,恒瑞医药,恒瑞医药关于2025年A股员工持股计划非交易过户完成的公告,2025-11-08 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224793061&orgId=gssh0600276&announcementTime=2025-11-08 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-11-08 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224793063&orgId=gssh0600276&announcementTime=2025-11-08 00:00:00
600276,恒瑞医药,恒瑞医药关于2022年员工持股计划部分份额解锁条件成就暨第三个锁定期届满的提示性公告,2025-11-08 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224793064&orgId=gssh0600276&announcementTime=2025-11-08 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-11-08 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224793717&orgId=gssh0600276&announcementTime=2025-11-08 00:00:00
600276,恒瑞医药,H股公告-证券变动月报表,2025-11-05 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224786026&orgId=gssh0600276&announcementTime=2025-11-05 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-11-05 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224786025&orgId=gssh0600276&announcementTime=2025-11-05 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-11-04 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224783682&orgId=gssh0600276&announcementTime=2025-11-04 00:00:00
600276,恒瑞医药,恒瑞医药关于回购公司A股股份的进展公告,2025-11-04 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224783323&orgId=gssh0600276&announcementTime=2025-11-04 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-11-04 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224783322&orgId=gssh0600276&announcementTime=2025-11-04 00:00:00
600276,恒瑞医药,恒瑞医药关于药物拟纳入优先审评程序的公告,2025-11-04 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224783321&orgId=gssh0600276&announcementTime=2025-11-04 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-10-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224772022&orgId=gssh0600276&announcementTime=2025-10-31 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-10-30 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224766701&orgId=gssh0600276&announcementTime=2025-10-30 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-10-29 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224751330&orgId=gssh0600276&announcementTime=2025-10-29 00:00:00
600276,恒瑞医药,恒瑞医药2025年第三季度报告,2025-10-28 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224743064&orgId=gssh0600276&announcementTime=2025-10-28 00:00:00
600276,恒瑞医药,恒瑞医药关于召开2025年第三季度业绩说明会的公告,2025-10-28 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224743062&orgId=gssh0600276&announcementTime=2025-10-28 00:00:00
600276,恒瑞医药,恒瑞医药关于药品上市许可申请获受理的提示性公告,2025-10-28 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224743060&orgId=gssh0600276&announcementTime=2025-10-28 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册批准的公告,2025-10-25 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224732861&orgId=gssh0600276&announcementTime=2025-10-25 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-10-24 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224728312&orgId=gssh0600276&announcementTime=2025-10-24 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-10-24 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224728337&orgId=gssh0600276&announcementTime=2025-10-24 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-10-23 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224725399&orgId=gssh0600276&announcementTime=2025-10-23 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-10-18 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224718591&orgId=gssh0600276&announcementTime=2025-10-18 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-10-15 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224711211&orgId=gssh0600276&announcementTime=2025-10-15 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-10-14 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224708186&orgId=gssh0600276&announcementTime=2025-10-14 00:00:00
600276,恒瑞医药,H股公告-董事会会议通告,2025-10-14 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224708185&orgId=gssh0600276&announcementTime=2025-10-14 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-10-14 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224707985&orgId=gssh0600276&announcementTime=2025-10-14 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-10-14 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224707984&orgId=gssh0600276&announcementTime=2025-10-14 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-10-14 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224707983&orgId=gssh0600276&announcementTime=2025-10-14 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-10-11 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224704890&orgId=gssh0600276&announcementTime=2025-10-11 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-10-10 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224702167&orgId=gssh0600276&announcementTime=2025-10-10 00:00:00
600276,恒瑞医药,H股公告-证券变动月报表,2025-10-10 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224702166&orgId=gssh0600276&announcementTime=2025-10-10 00:00:00
600276,恒瑞医药,恒瑞医药关于回购公司A股股份的进展公告,2025-10-10 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224701934&orgId=gssh0600276&announcementTime=2025-10-10 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-10-01 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224696405&orgId=gssh0600276&announcementTime=2025-10-01 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-10-01 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224696152&orgId=gssh0600276&announcementTime=2025-10-01 00:00:00
600276,恒瑞医药,恒瑞医药董监高减持股份结果公告,2025-10-01 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224696407&orgId=gssh0600276&announcementTime=2025-10-01 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-10-01 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224696406&orgId=gssh0600276&announcementTime=2025-10-01 00:00:00
600276,恒瑞医药,恒瑞医药关于药品上市许可申请获受理的提示性公告,2025-10-01 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224696408&orgId=gssh0600276&announcementTime=2025-10-01 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-09-30 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224689620&orgId=gssh0600276&announcementTime=2025-09-30 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-09-30 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224688533&orgId=gssh0600276&announcementTime=2025-09-30 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-09-30 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224688534&orgId=gssh0600276&announcementTime=2025-09-30 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-09-27 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224684914&orgId=gssh0600276&announcementTime=2025-09-27 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-09-25 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224679151&orgId=gssh0600276&announcementTime=2025-09-25 00:00:00
600276,恒瑞医药,恒瑞医药关于与GlenmarkSpecialty公司签署瑞康曲妥珠单抗项目授权许可协议的公告,2025-09-25 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224679075&orgId=gssh0600276&announcementTime=2025-09-25 00:00:00
600276,恒瑞医药,恒瑞医药关于药品上市许可申请获受理的提示性公告,2025-09-24 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224676949&orgId=gssh0600276&announcementTime=2025-09-24 00:00:00
600276,恒瑞医药,恒瑞医药关于药品上市许可申请获受理的提示性公告,2025-09-24 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224676948&orgId=gssh0600276&announcementTime=2025-09-24 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-09-24 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224676950&orgId=gssh0600276&announcementTime=2025-09-24 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-09-24 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224677596&orgId=gssh0600276&announcementTime=2025-09-24 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-09-23 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224673866&orgId=gssh0600276&announcementTime=2025-09-23 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-09-19 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224668009&orgId=gssh0600276&announcementTime=2025-09-19 00:00:00
600276,恒瑞医药,恒瑞医药关于药物纳入拟突破性治疗品种公示名单的公告,2025-09-19 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224668008&orgId=gssh0600276&announcementTime=2025-09-19 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-09-19 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224668007&orgId=gssh0600276&announcementTime=2025-09-19 00:00:00
600276,恒瑞医药,恒瑞医药关于药品上市许可申请获受理并纳入优先审评程序的提示性公告,2025-09-18 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224665855&orgId=gssh0600276&announcementTime=2025-09-18 00:00:00
600276,恒瑞医药,恒瑞医药关于药品纳入拟突破性治疗品种公示名单的公告,2025-09-18 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224665854&orgId=gssh0600276&announcementTime=2025-09-18 00:00:00
600276,恒瑞医药,恒瑞医药2025年第一次临时股东会法律意见书,2025-09-17 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224664432&orgId=gssh0600276&announcementTime=2025-09-17 00:00:00
600276,恒瑞医药,恒瑞医药2025年第一次临时股东会决议公告,2025-09-17 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224664431&orgId=gssh0600276&announcementTime=2025-09-17 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-09-17 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224664434&orgId=gssh0600276&announcementTime=2025-09-17 00:00:00
600276,恒瑞医药,恒瑞医药2025年A股员工持股计划,2025-09-17 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224664433&orgId=gssh0600276&announcementTime=2025-09-17 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-09-12 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224652264&orgId=gssh0600276&announcementTime=2025-09-12 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册批准的公告,2025-09-10 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224646676&orgId=gssh0600276&announcementTime=2025-09-10 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-09-06 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224640335&orgId=gssh0600276&announcementTime=2025-09-06 00:00:00
600276,恒瑞医药,恒瑞医药关于与Braveheart Bio签署HRS-1893项目授权许可协议的公告,2025-09-05 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224640180&orgId=gssh0600276&announcementTime=2025-09-05 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-09-05 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224638822&orgId=gssh0600276&announcementTime=2025-09-05 00:00:00
600276,恒瑞医药,恒瑞医药关于首次回购公司A股股份的公告,2025-09-05 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224638821&orgId=gssh0600276&announcementTime=2025-09-05 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-09-05 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224638820&orgId=gssh0600276&announcementTime=2025-09-05 00:00:00
600276,恒瑞医药,恒瑞医药2025年第一次临时股东会会议资料,2025-09-04 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224636187&orgId=gssh0600276&announcementTime=2025-09-04 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-09-03 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224634869&orgId=gssh0600276&announcementTime=2025-09-03 00:00:00
600276,恒瑞医药,恒瑞医药关于回购公司A股股份的进展公告,2025-09-03 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224634868&orgId=gssh0600276&announcementTime=2025-09-03 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-09-03 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224634867&orgId=gssh0600276&announcementTime=2025-09-03 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册批准的公告,2025-09-02 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224631054&orgId=gssh0600276&announcementTime=2025-09-02 00:00:00
600276,恒瑞医药,恒瑞医药关于药品上市许可申请获受理的提示性公告,2025-09-02 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224631055&orgId=gssh0600276&announcementTime=2025-09-02 00:00:00
600276,恒瑞医药,H股公告-证券变动月报表,2025-09-02 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224631743&orgId=gssh0600276&announcementTime=2025-09-02 00:00:00
600276,恒瑞医药,恒瑞医药关于以集中竞价交易方式回购公司A股股份事项的回购报告书,2025-08-27 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224581924&orgId=gssh0600276&announcementTime=2025-08-27 00:00:00
600276,恒瑞医药,恒瑞医药关于召开2025年第一次临时股东会的通知,2025-08-27 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224581923&orgId=gssh0600276&announcementTime=2025-08-27 00:00:00
600276,恒瑞医药,恒瑞医药关于回购公司A股股份事项前十大股东及前十大无限售条件股东持股情况的公告,2025-08-27 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224581925&orgId=gssh0600276&announcementTime=2025-08-27 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-08-26 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224564986&orgId=gssh0600276&announcementTime=2025-08-26 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-08-26 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224564985&orgId=gssh0600276&announcementTime=2025-08-26 00:00:00
600276,恒瑞医药,恒瑞医药关于召开2025年半年度业绩说明会的公告,2025-08-23 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224558765&orgId=gssh0600276&announcementTime=2025-08-23 00:00:00
600276,恒瑞医药,恒瑞医药第九届董事会第十八次会议决议公告,2025-08-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224526671&orgId=gssh0600276&announcementTime=2025-08-21 00:00:00
600276,恒瑞医药,恒瑞医药关于以集中竞价交易方式回购公司A股股份方案的公告,2025-08-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224526664&orgId=gssh0600276&announcementTime=2025-08-21 00:00:00
600276,恒瑞医药,恒瑞医药关于以自有闲置资金进行委托理财的公告,2025-08-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224526665&orgId=gssh0600276&announcementTime=2025-08-21 00:00:00
600276,恒瑞医药,恒瑞医药2025年A股员工持股计划（草案）摘要,2025-08-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224526666&orgId=gssh0600276&announcementTime=2025-08-21 00:00:00
600276,恒瑞医药,恒瑞医药董事会薪酬与考核委员会关于公司2025年A股员工持股计划相关事项的核查意见,2025-08-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224526667&orgId=gssh0600276&announcementTime=2025-08-21 00:00:00
600276,恒瑞医药,北京市中伦律师事务所关于江苏恒瑞医药股份有限公司2025年A股员工持股计划的法律意见书,2025-08-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224526668&orgId=gssh0600276&announcementTime=2025-08-21 00:00:00
600276,恒瑞医药,恒瑞医药2025年A股员工持股计划管理办法,2025-08-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224526670&orgId=gssh0600276&announcementTime=2025-08-21 00:00:00
600276,恒瑞医药,恒瑞医药2025年A股员工持股计划（草案）,2025-08-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224526669&orgId=gssh0600276&announcementTime=2025-08-21 00:00:00
600276,恒瑞医药,恒瑞医药关于聘请2025年度境外审计机构的公告,2025-08-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224526672&orgId=gssh0600276&announcementTime=2025-08-21 00:00:00
600276,恒瑞医药,恒瑞医药第六届职工代表大会第三次会议决议公告,2025-08-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224526673&orgId=gssh0600276&announcementTime=2025-08-21 00:00:00
600276,恒瑞医药,恒瑞医药2025年半年度报告摘要,2025-08-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224526674&orgId=gssh0600276&announcementTime=2025-08-21 00:00:00
600276,恒瑞医药,恒瑞医药2025年半年度报告,2025-08-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224526675&orgId=gssh0600276&announcementTime=2025-08-21 00:00:00
600276,恒瑞医药,恒瑞医药第九届监事会第十三次会议决议公告,2025-08-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224526676&orgId=gssh0600276&announcementTime=2025-08-21 00:00:00
600276,恒瑞医药,H股公告-截至2025年6月30日止六个月之中期业绩公告,2025-08-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224527059&orgId=gssh0600276&announcementTime=2025-08-21 00:00:00
600276,恒瑞医药,H股公告-建议采纳2025年A股员工持股计划,2025-08-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224527060&orgId=gssh0600276&announcementTime=2025-08-21 00:00:00
600276,恒瑞医药,恒瑞医药关于药品上市许可申请获受理的提示性公告,2025-08-19 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224502644&orgId=gssh0600276&announcementTime=2025-08-19 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-08-19 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224502645&orgId=gssh0600276&announcementTime=2025-08-19 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-08-15 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224486284&orgId=gssh0600276&announcementTime=2025-08-15 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-08-14 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224473269&orgId=gssh0600276&announcementTime=2025-08-14 00:00:00
600276,恒瑞医药,恒瑞医药关于药品上市许可申请获受理的提示性公告,2025-08-13 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224461213&orgId=gssh0600276&announcementTime=2025-08-13 00:00:00
600276,恒瑞医药,恒瑞医药关于药品纳入拟突破性治疗品种公示名单的公告,2025-08-12 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224443989&orgId=gssh0600276&announcementTime=2025-08-12 00:00:00
600276,恒瑞医药,H股公告-董事会会议通告,2025-08-09 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224440889&orgId=gssh0600276&announcementTime=2025-08-09 00:00:00
600276,恒瑞医药,恒瑞医药关于获得美国FDA孤儿药资格认定的公告,2025-08-07 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224413262&orgId=gssh0600276&announcementTime=2025-08-07 00:00:00
600276,恒瑞医药,H股公告-证券变动月报表,2025-08-05 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224385945&orgId=gssh0600276&announcementTime=2025-08-05 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-08-01 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224353491&orgId=gssh0600276&announcementTime=2025-08-01 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-08-01 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224353492&orgId=gssh0600276&announcementTime=2025-08-01 00:00:00
600276,恒瑞医药,恒瑞医药关于与GSK签署合作、选择权和许可协议的公告,2025-07-28 07:50:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224312307&orgId=gssh0600276&announcementTime=2025-07-28 07:50:00
600276,恒瑞医药,恒瑞医药第九届董事会第十七次会议决议公告,2025-07-26 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224299593&orgId=gssh0600276&announcementTime=2025-07-26 00:00:00
600276,恒瑞医药,恒瑞医药关于收购控股子公司少数股东股权暨关联交易的公告,2025-07-26 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224299591&orgId=gssh0600276&announcementTime=2025-07-26 00:00:00
600276,恒瑞医药,内部审计管理制度,2025-07-26 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224299597&orgId=gssh0600276&announcementTime=2025-07-26 00:00:00
600276,恒瑞医药,恒瑞医药拟收购成都盛迪医药有限公司部分股权的资产评估报告,2025-07-26 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224299594&orgId=gssh0600276&announcementTime=2025-07-26 00:00:00
600276,恒瑞医药,恒瑞医药第九届监事会第十二次会议决议公告,2025-07-26 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224299596&orgId=gssh0600276&announcementTime=2025-07-26 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-07-25 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224281733&orgId=gssh0600276&announcementTime=2025-07-25 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-07-25 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224281732&orgId=gssh0600276&announcementTime=2025-07-25 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-07-18 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224202263&orgId=gssh0600276&announcementTime=2025-07-18 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-07-18 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224202262&orgId=gssh0600276&announcementTime=2025-07-18 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-07-09 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224102768&orgId=gssh0600276&announcementTime=2025-07-09 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-07-09 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224102767&orgId=gssh0600276&announcementTime=2025-07-09 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-07-04 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224070788&orgId=gssh0600276&announcementTime=2025-07-04 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册批准的公告,2025-07-04 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224070785&orgId=gssh0600276&announcementTime=2025-07-04 00:00:00
600276,恒瑞医药,H股公告-证券变动月报表,2025-07-03 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224066902&orgId=gssh0600276&announcementTime=2025-07-03 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册批准的公告,2025-07-01 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224037811&orgId=gssh0600276&announcementTime=2025-07-01 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册批准的公告,2025-07-01 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224037810&orgId=gssh0600276&announcementTime=2025-07-01 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-06-28 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1224013690&orgId=gssh0600276&announcementTime=2025-06-28 00:00:00
600276,恒瑞医药,H股公告-翌日披露报表,2025-06-25 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223972863&orgId=gssh0600276&announcementTime=2025-06-25 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-06-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223951591&orgId=gssh0600276&announcementTime=2025-06-21 00:00:00
600276,恒瑞医药,恒瑞医药关于悉数行使超额配售权、稳定价格行动及稳定价格期结束的公告,2025-06-20 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223935483&orgId=gssh0600276&announcementTime=2025-06-20 00:00:00
600276,恒瑞医药,恒瑞医药董监高减持股份计划公告,2025-06-16 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223880080&orgId=gssh0600276&announcementTime=2025-06-16 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-06-14 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223876924&orgId=gssh0600276&announcementTime=2025-06-14 00:00:00
600276,恒瑞医药,H股公告 证券变动月报表,2025-06-06 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223786805&orgId=gssh0600276&announcementTime=2025-06-06 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-06-06 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223785786&orgId=gssh0600276&announcementTime=2025-06-06 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册批准的公告,2025-06-06 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223785785&orgId=gssh0600276&announcementTime=2025-06-06 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-05-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223732170&orgId=gssh0600276&announcementTime=2025-05-31 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册批准的公告,2025-05-30 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223721813&orgId=gssh0600276&announcementTime=2025-05-30 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册批准的公告,2025-05-30 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223721812&orgId=gssh0600276&announcementTime=2025-05-30 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册批准的公告,2025-05-30 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223721811&orgId=gssh0600276&announcementTime=2025-05-30 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-05-27 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223682273&orgId=gssh0600276&announcementTime=2025-05-27 00:00:00
600276,恒瑞医药,恒瑞医药关于境外上市外资股（H股）挂牌并上市交易的公告,2025-05-24 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223644390&orgId=gssh0600276&announcementTime=2025-05-24 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册证书的公告,2025-05-23 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223632753&orgId=gssh0600276&announcementTime=2025-05-23 00:00:00
600276,恒瑞医药,恒瑞医药关于境外上市外资股（H股）公开发行价格的公告,2025-05-22 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223626689&orgId=gssh0600276&announcementTime=2025-05-22 00:00:00
600276,恒瑞医药,恒瑞医药2024年年度权益分派实施公告,2025-05-19 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223581229&orgId=gssh0600276&announcementTime=2025-05-19 00:00:00
600276,恒瑞医药,恒瑞医药差异化分红事项法律意见书,2025-05-19 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223581230&orgId=gssh0600276&announcementTime=2025-05-19 00:00:00
600276,恒瑞医药,恒瑞医药关于股份回购实施结果暨股份变动的公告,2025-05-16 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223556561&orgId=gssh0600276&announcementTime=2025-05-16 00:00:00
600276,恒瑞医药,恒瑞医药关于刊发H股招股说明书、H股发行价格区间及H股香港公开发售等事宜的公告,2025-05-15 08:20:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223546921&orgId=gssh0600276&announcementTime=2025-05-15 08:20:00
600276,恒瑞医药,恒瑞医药第九届董事会第十六次会议决议公告,2025-05-13 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223525900&orgId=gssh0600276&announcementTime=2025-05-13 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-05-10 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223511815&orgId=gssh0600276&announcementTime=2025-05-10 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-05-10 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223511814&orgId=gssh0600276&announcementTime=2025-05-10 00:00:00
600276,恒瑞医药,恒瑞医药关于药品上市许可申请获受理的提示性公告,2025-05-09 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223494619&orgId=gssh0600276&announcementTime=2025-05-09 00:00:00
600276,恒瑞医药,恒瑞医药关于股份回购进展公告,2025-05-08 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223488376&orgId=gssh0600276&announcementTime=2025-05-08 00:00:00
600276,恒瑞医药,恒瑞医药关于刊发境外上市外资股（H 股）发行聆讯后资料集的公告,2025-05-06 08:17:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223471216&orgId=gssh0600276&announcementTime=2025-05-06 08:17:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-04-30 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223406407&orgId=gssh0600276&announcementTime=2025-04-30 00:00:00
600276,恒瑞医药,恒瑞医药2024年年度股东会法律意见书,2025-04-29 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223368179&orgId=gssh0600276&announcementTime=2025-04-29 00:00:00
600276,恒瑞医药,恒瑞医药2024年年度股东会决议公告,2025-04-29 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223368178&orgId=gssh0600276&announcementTime=2025-04-29 00:00:00
600276,恒瑞医药,恒瑞医药关于发行境外上市外资股（H 股）获得中国证监会备案的公告,2025-04-28 08:21:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223349578&orgId=gssh0600276&announcementTime=2025-04-28 08:21:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-04-28 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223348098&orgId=gssh0600276&announcementTime=2025-04-28 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-04-26 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223304259&orgId=gssh0600276&announcementTime=2025-04-26 00:00:00
600276,恒瑞医药,恒瑞医药2025年第一季度报告,2025-04-25 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223274888&orgId=gssh0600276&announcementTime=2025-04-25 00:00:00
600276,恒瑞医药,恒瑞医药关于召开2025年第一季度业绩说明会的公告,2025-04-25 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223274887&orgId=gssh0600276&announcementTime=2025-04-25 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-04-22 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223185287&orgId=gssh0600276&announcementTime=2025-04-22 00:00:00
600276,恒瑞医药,恒瑞医药2024年年度股东会会议资料,2025-04-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223174752&orgId=gssh0600276&announcementTime=2025-04-21 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-04-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223174751&orgId=gssh0600276&announcementTime=2025-04-21 00:00:00
600276,恒瑞医药,恒瑞医药关于召开2024年年度股东会的提示性公告,2025-04-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223174750&orgId=gssh0600276&announcementTime=2025-04-21 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-04-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223174749&orgId=gssh0600276&announcementTime=2025-04-21 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-04-19 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223143239&orgId=gssh0600276&announcementTime=2025-04-19 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-04-19 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223143238&orgId=gssh0600276&announcementTime=2025-04-19 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-04-15 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223091440&orgId=gssh0600276&announcementTime=2025-04-15 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-04-15 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223091439&orgId=gssh0600276&announcementTime=2025-04-15 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-04-14 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223086106&orgId=gssh0600276&announcementTime=2025-04-14 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-04-14 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223086105&orgId=gssh0600276&announcementTime=2025-04-14 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册证书的公告,2025-04-10 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223043624&orgId=gssh0600276&announcementTime=2025-04-10 00:00:00
600276,恒瑞医药,恒瑞医药关于召开2024年度业绩暨现金分红说明会的公告,2025-04-10 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223043623&orgId=gssh0600276&announcementTime=2025-04-10 00:00:00
600276,恒瑞医药,恒瑞医药关于股份回购进展公告,2025-04-09 12:23:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223039658&orgId=gssh0600276&announcementTime=2025-04-09 12:23:00
600276,恒瑞医药,恒瑞医药关于获得药品注册证书的公告,2025-04-09 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223030317&orgId=gssh0600276&announcementTime=2025-04-09 00:00:00
600276,恒瑞医药,恒瑞医药关于2023年员工持股计划第一个锁定期解锁执行完毕的公告,2025-04-09 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223030316&orgId=gssh0600276&announcementTime=2025-04-09 00:00:00
600276,恒瑞医药,"恒瑞医药关于与Merck KGaA, Darmstadt, Germany签署SHR7280项目授权许可协议的公告",2025-04-08 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223018741&orgId=gssh0600276&announcementTime=2025-04-08 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-04-04 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1223004398&orgId=gssh0600276&announcementTime=2025-04-04 00:00:00
600276,恒瑞医药,江苏恒瑞医药股份有限公司章程（2025年4月）,2025-04-03 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222992577&orgId=gssh0600276&announcementTime=2025-04-03 00:00:00
600276,恒瑞医药,恒瑞医药公司章程修正案,2025-04-03 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222992575&orgId=gssh0600276&announcementTime=2025-04-03 00:00:00
600276,恒瑞医药,恒瑞医药关于召开2024年年度股东会的通知,2025-04-03 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222992574&orgId=gssh0600276&announcementTime=2025-04-03 00:00:00
600276,恒瑞医药,江苏恒瑞医药股份有限公司章程（草案 2025年4月）,2025-04-03 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222992573&orgId=gssh0600276&announcementTime=2025-04-03 00:00:00
600276,恒瑞医药,恒瑞医药第九届董事会第十四次会议决议公告,2025-04-03 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222992576&orgId=gssh0600276&announcementTime=2025-04-03 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-04-02 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222981303&orgId=gssh0600276&announcementTime=2025-04-02 00:00:00
600276,恒瑞医药,恒瑞医药关于股份回购进展公告,2025-04-02 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222981300&orgId=gssh0600276&announcementTime=2025-04-02 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册证书的公告,2025-04-01 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222969633&orgId=gssh0600276&announcementTime=2025-04-01 00:00:00
600276,恒瑞医药,恒瑞医药2024年度独立董事述职报告（曾庆生）,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961963&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药2024年度内部控制评价报告,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961966&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药2025年度“提质增效重回报”行动方案,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961965&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药2024年度内部控制审计报告,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961964&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药2024年度利润分配方案公告,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961959&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药2024年年度报告,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961962&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药2024年环境、社会及管治报告,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961961&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药董事会审计委员会对会计师事务所2024年度履行监督职责情况报告,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961960&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药关于续聘会计师事务所的公告,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961968&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药2024年度独立董事述职报告（董家鸿）,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961958&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,关于江苏恒瑞医药股份有限公司2024年度非经营性资金占用及其他关联资金往来情况的专项说明,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961967&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药未来三年（2025—2027年度）股东分红回报规划,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961970&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药2024年年度报告摘要,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961969&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药2024年度审计委员会履职情况汇总报告,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961971&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药第九届董事会第十三次会议决议公告,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961972&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药2024年度独立董事述职报告（孙金云）,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961973&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药2024年度审计报告,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961974&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药第九届监事会第十次会议决议公告,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961975&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药董事会关于独立董事独立性自查情况的专项报告,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961976&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药2024年度会计师事务所履职情况评估报告,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222961977&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药关于药物纳入拟突破性治疗品种公示名单的公告,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222962616&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药关于2023年员工持股计划部分份额解锁条件成就的提示性公告,2025-03-31 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222962617&orgId=gssh0600276&announcementTime=2025-03-31 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-03-28 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222922120&orgId=gssh0600276&announcementTime=2025-03-28 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-03-28 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222922119&orgId=gssh0600276&announcementTime=2025-03-28 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-03-27 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222909423&orgId=gssh0600276&announcementTime=2025-03-27 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-03-27 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222909422&orgId=gssh0600276&announcementTime=2025-03-27 00:00:00
600276,恒瑞医药,恒瑞医药关于与Merck Sharp & Dohme LLC签署HRS-5346项目授权许可协议的公告,2025-03-26 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222895678&orgId=gssh0600276&announcementTime=2025-03-26 00:00:00
600276,恒瑞医药,恒瑞医药收到关于注射用卡瑞利珠单抗的完整回复信的公告,2025-03-22 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222865830&orgId=gssh0600276&announcementTime=2025-03-22 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册证书的公告,2025-03-22 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222865828&orgId=gssh0600276&announcementTime=2025-03-22 00:00:00
600276,恒瑞医药,恒瑞医药关于药品纳入拟突破性治疗品种公示名单的公告,2025-03-20 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222844614&orgId=gssh0600276&announcementTime=2025-03-20 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-03-18 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222820435&orgId=gssh0600276&announcementTime=2025-03-18 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册证书的公告,2025-03-17 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222816001&orgId=gssh0600276&announcementTime=2025-03-17 00:00:00
600276,恒瑞医药,恒瑞医药关于股份回购进展公告,2025-03-12 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222767706&orgId=gssh0600276&announcementTime=2025-03-12 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-03-10 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222753422&orgId=gssh0600276&announcementTime=2025-03-10 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-03-08 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222742822&orgId=gssh0600276&announcementTime=2025-03-08 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-03-07 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222732387&orgId=gssh0600276&announcementTime=2025-03-07 00:00:00
600276,恒瑞医药,恒瑞医药关于股份回购进展公告,2025-03-05 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222706254&orgId=gssh0600276&announcementTime=2025-03-05 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-02-28 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222660690&orgId=gssh0600276&announcementTime=2025-02-28 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-02-27 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222649853&orgId=gssh0600276&announcementTime=2025-02-27 00:00:00
600276,恒瑞医药,恒瑞医药关于药品临床试验进展的公告,2025-02-24 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222618679&orgId=gssh0600276&announcementTime=2025-02-24 00:00:00
600276,恒瑞医药,恒瑞医药关于药品上市许可申请获受理的提示性公告,2025-02-18 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222559098&orgId=gssh0600276&announcementTime=2025-02-18 00:00:00
600276,恒瑞医药,恒瑞医药关于药品上市许可申请获受理的提示性公告,2025-02-17 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222554282&orgId=gssh0600276&announcementTime=2025-02-17 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-02-14 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222535270&orgId=gssh0600276&announcementTime=2025-02-14 00:00:00
600276,恒瑞医药,恒瑞医药关于股份回购进展公告,2025-02-06 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222458492&orgId=gssh0600276&announcementTime=2025-02-06 00:00:00
600276,恒瑞医药,恒瑞医药关于药品上市许可申请获受理的提示性公告,2025-01-24 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222417489&orgId=gssh0600276&announcementTime=2025-01-24 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册证书的公告,2025-01-21 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222377566&orgId=gssh0600276&announcementTime=2025-01-21 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-01-17 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222353953&orgId=gssh0600276&announcementTime=2025-01-17 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-01-15 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222331503&orgId=gssh0600276&announcementTime=2025-01-15 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药品注册证书的公告,2025-01-13 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222314246&orgId=gssh0600276&announcementTime=2025-01-13 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-01-11 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222297185&orgId=gssh0600276&announcementTime=2025-01-11 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-01-11 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222297184&orgId=gssh0600276&announcementTime=2025-01-11 00:00:00
600276,恒瑞医药,恒瑞医药关于药品上市许可申请获受理的提示性公告,2025-01-10 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222283951&orgId=gssh0600276&announcementTime=2025-01-10 00:00:00
600276,恒瑞医药,恒瑞医药关于向香港联交所递交境外上市外资股（H股）发行并上市的申请并刊发申请资料的公告,2025-01-07 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222247218&orgId=gssh0600276&announcementTime=2025-01-07 00:00:00
600276,恒瑞医药,恒瑞医药关于获得药物临床试验批准通知书的公告,2025-01-04 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222221299&orgId=gssh0600276&announcementTime=2025-01-04 00:00:00
600276,恒瑞医药,恒瑞医药关于股份回购进展公告,2025-01-03 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222204151&orgId=gssh0600276&announcementTime=2025-01-03 00:00:00
600276,恒瑞医药,恒瑞医药关于与IDEAYA Biosciences签署SHR-4849项目授权许可协议的公告,2024-12-30 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222173783&orgId=gssh0600276&announcementTime=2024-12-30 00:00:00
600276,恒瑞医药,恒瑞医药关于2024年员工持股计划非交易过户完成的公告,2024-12-30 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222173782&orgId=gssh0600276&announcementTime=2024-12-30 00:00:00
600276,恒瑞医药,恒瑞医药2024年员工持股计划第一次持有人会议决议公告,2024-12-30 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222173781&orgId=gssh0600276&announcementTime=2024-12-30 00:00:00
600276,恒瑞医药,恒瑞医药2024年第二次临时股东会法律意见书,2024-12-27 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222155648&orgId=gssh0600276&announcementTime=2024-12-27 00:00:00
600276,恒瑞医药,恒瑞医药2024年第二次临时股东会决议公告,2024-12-27 00:00:00,http://www.cninfo.com.cn/new/disclosure/detail?stockCode=600276&announcementId=1222155647&orgId=gssh0600276&announcementTime=2024-12-27 00:00:00
